Covered recipient · General Payments record
NAVYA TALLURI
Allopathic & Osteopathic Physicians Family Medicine
This page merges CMS profile IDs 5144376, 7225728 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2021
$430.85
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $137.49 | 8 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $37.03 | 2 |
| Lilly USA, LLC | $33.68 | 2 |
| ABBVIE INC. | $22.38 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.76 | 1 |
| Amarin Pharma Inc. | $14.48 | 1 |
| Novo Nordisk AS | $14.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $22.38 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796132669 | CMS |
| Amarin Pharma Inc. | $14.48 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815278053 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.76 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763372220 | CMS |
| GlaxoSmithKline, LLC. | $17.04 | 01/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802912275 | CMS |
| GlaxoSmithKline, LLC. | $19.99 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 803034761 | CMS |
| Lilly USA, LLC | $20.10 | 03/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818593991 | CMS |
| Lilly USA, LLC | $13.58 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818672749 | CMS |
| Novo Nordisk Inc | $14.16 | 02/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811082485 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
- Merged CMS profile IDs
- 5144376, 7225728
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.